New hope for advanced lung cancer patients with no options left

NCT ID NCT07423169

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment for people with advanced lung cancer that cannot be removed by surgery. It combines a special type of radiation that targets only the center of the tumor with an immunotherapy drug that was used before. The goal is to see if this combination can slow down the cancer better than the immunotherapy alone. About 10 adults who have run out of standard treatment options will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BULKY TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma of Lung lung adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Radiation Oncology Department

    RECRUITING

    Krems, Austria, 3500, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.